TABLE 1

Characteristics of the control subjects and the patients in the diabetes group

Control subjectsDiabetes group
Preoperative3 months6 months12 months
n1211111111
M/F3/92/9
Age (years)36.8 ± 3.040.1 ± 2.5
Weight (kg)64.5 ± 3.0143.3 ± 9.5112.5 ± 7.094.9 ± 6.477.8 ± 4.5
BMI (kg/m2)22.3 ± 0.553.2 ± 2.041.7 ± 1.435.3 ± 1.629.2 ± 1.7
FFM (kg)75.3 ± 2.965.5 ± 5.061.9 ± 5.555.1 ± 4.7
Fat mass (kg)60.9 ± 2.945.6 ± 3.033.1 ± 2.522.6 ± 3.4
Fasting glucose (mmol/l)4.7 ± 0.11 (4.2–5.3)9.5 ± 0.83 (6.9–15.5)5.1 ± 0.17 (4.2–5.9)4.7 ± 0.13 (4.1–5.3)4.5 ± 0.13 (3.9–5.1)
Fasting insulin (pmol/l)44.4 ± 6.0168.4 ± 25.955.3 ± 9.133.5 ± 6.137.7 ± 4.4
QUICKI0.365 ± 0.0070.278 ± 0.0070.357 ± 0.0150.396 ± 0.0190.378 ± 0.011
1st phase insulin (pmol/l)332.4 ± 39.624.0 ± 22.7208.8 ± 43.4261.8 ± 40.4248.5 ± 33.1
2nd phase insulin (pmol/l)207.0 ± 18.6410.9 ± 57.1235.9 ± 43.2172.2 ± 30.2127.6 ± 22.5
  • Data are means ± SE (range) unless otherwise indicated.